Still have a question? Ask your question here
Personalised
Behavioural interventions are personalised and ever-evolving to adapt to the user’s needs
AlcoChange is here to help with reducing and abstaining from alcohol consumption and improve liver health , AlcoChange is the personalised behavioural change therapist in your pocket that observes your behaviours, adapts to your preferences and helps you achieve your abstinence goal.
Deaths from liver disease is increasing at an alarming rate and this is primarily associated with increasing alcohol consumption. Urgent action is now required to deal with this increasing problem.
The current approach is associated with Alcohol Care Teams engaging with individuals to provide counselling, psychological appraisal and where possible drug therapy. However, with the increasing numbers of individuals presenting with alcohol-related liver conditions, an alternative or additional approach is required.
CyberLiver addresses this urgent clinical need through an innovative AlcoChange – a novel, patented, CE marked digital therapeutic based on a smartphone app and breathalyser, developed with feedback from alcohol service users and validated in a pilot study in a clinical setting in the UK.
AlcoChange allows self-monitoring habits like craving, alcohol use/abstinence and breath alcohol, and provides motivational messaging in response to patient triggers of alcohol consumption.
AlcoChange (a smartphone app with an optional breathalyser) can help patients with alcohol-related liver disease (ArLD) abstain from, or reduce, alcohol use.
90- or 180-day tailored behavioural change therapy
Clinician portal
AlcoChange patient app
Digital Breathalyser
Personalised and continuously evolving behaviour change
90- or 180-day therapy
24/7 access for clinicians
Goal-setting tools
Daily/weekly/monthly journal to tracking drinks, abstinence, cravings and breath alcohol tests
Daily motivational messages for encouraging positive behavioural change
AlcoChange is proven to help people drink reduce alcohol
consumption and work towards abstinence.
AlcoChange is a patented groundbreaking Digital Therapeutic solution that is designed to help users abstain from or reduce alcohol consumption
AlcoChange was created based on an amalgamation of various behavioural change techniques,AlcoChange brings the science of behaviour change to you by utilising a unique combination of various behavioural change techniques through a patented CyberLiver Behavioural Change methodology.
Behavioural interventions are personalised and ever-evolving to adapt to the user’s needs
Encourages engagement and participation through regular motivations, nudges and follow-ups
Learn how to identify triggers, break negative behaviors, and develop healthier responses
Easy to use, quick, visual means to self monitor alcohol consumption
Breathalyser can be connected using bluetooth or USB cable
Regular reminders throughout the therapy for self-monitoring
Visual images and cues for easy connection and testing
Read more about the Digital Breathalyser
In hospitals, Alcohol Care Teams (ACTs) work to help high-risk patients with liver disease to abstain from consuming alcohol. However, increasing numbers of patients year-on-year mean ACTs cannot review every patient. AlcoChange could help reduce the number of hospital admissions and deaths associated with alcohol-related liver disease with the help of a behavioural change smartphone app.
AlcoChange has already been shown to have positive benefits in an initial study carried out at the Royal Free Hospital in London. Larger clinical trials are underway, with one of the studies being coordinated by the Southampton Clinical Trials Unit (SCTU).
If you are a healthcare provider and wish to partner with us for a Clinical study, please Click here.
If you are looking to improve your liver health outcome, please check with your healthcare provider whether they offer the AlcoChange prescription therapy. AlcoChange therapy is currently been provided only via your Healthcare provider.
If you are a healthcare provider and would like to partner with us for a clinical trial, please click here
AlcoChange prescription therapy is typically 90 days or 180 days
Please click here to learn about what comes along with AlcoChange.
As part of the enrolment and on-boarding, you will be guided step by step on how to use the AlcoChange application and breathalyser.
As part of the AlcoChange clinician setup, you will have access to patient details and real-time patient monitoring using an intuitive clinician dashboard that you can access from your device.
If you have any technical issues with the AlcoChange application or breathalyser, please reach out to our support team.
Still have a question? Ask your question here
Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere ipsum dolor sit amet, consectetur elit.
Clinical
Cyberliver Announces Poster Presentation of AlcoChange
Pilot Study at The Liver Meeting 2018
Read More
Clinical
AlcoChange: a smartphone tool to reduce alcohol use and admissions in alcoholic liver disease
Royal Free London NHS Foundation Trust
Read MoreIf you have questions about AlcoChange, or are having technical or other issues, our experts are ready to help.
3rd Floor Stanmore House ,15/19 Church Road Stanmore, Middlesex HA7 4AR, GB